Registered entities
Aligos Therapeutics, Inc.
Reg. No. 82-4724808United States
Innovation
72 patent families (30 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 3,940 times.
| Year | Filings |
|---|---|
| 2020 | 11 |
| 2021 | 23 |
| 2022 | 31 |
| 2023 | 39 |
| 2024 | 38 |
| 2025 | 33 |
| 2026 | 8 |
Social engagement
Social engagement: 7.5K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Wellington.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Private equity | 2 | 22% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 3 | 33% |
Recent activity
3 Jun 2026
Event
EASL | The Home of Hepatology Congress 2026
27 May 2026
Event
EASL Congress 2026
14 May 2026
Event
33rd European Congress on Obesity